Senti Biosciences Inc.

About Senti Biosciences Inc.

Senti Bio is a clinical-stage company focused on creating a new generation of smarter medicines for patients with incurable diseases, particularly cancer. They utilize synthetic biology to design proprietary Gene Circuits, which reprogram cells to sense, compute, and respond to their environments. Their goal is to develop therapeutics that precisely target cancer cells while sparing healthy cells, increase specificity, and control drug expression post-administration.

Products & Services

SENTI-202:A lead product candidate in clinical trials in the U.S. for the treatment of acute myeloid leukemia (AML).

Cell Therapy Programs:A pipeline of product candidates using cell therapy to address major challenges in oncology and provide potentially lifesaving treatments for cancer patients.

Specialties

Synthetic Biology Gene Circuit Technology Cell Therapy Oncology Off-the-Shelf NK Cells

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 1000000 MR: - FA: $1.0 million FAN: 1000000	D: 2025-05-22 FD: 2025-05-22	1 investors
2	RT: PIPE Financing T: - FT: PIPE Financing	A: 11500000 MR: - FA: $11.5 million FAN: 11500000	D: 2025-01-06 FD: 2025-01-06	5 investors
3	RT: Private Placement T: - FT: Private Placement	A: 37600000 MR: - FA: $37.6 million FAN: 37600000	D: 2024-12-02 FD: 2024-12-02	6 investors
4	RT: Grant T: - FT: Grant	A: 8000000 MR: - FA: $8 million FAN: 8000000	D: 2024-07-01 FD: 2024-07-01	1 investors

Grant Latest

2025-05-22

$1.0M

1 investor (Pro only)

PIPE Financing 2025-01-06

$11.5M

Private Placement 2024-12-02

$37.6M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Timothy Lu, M.D., Ph.D.

Co-Founder and Chief Executive Officer

J

James Collins

Scientific Co-Founder

B

Brenda Cooperstone

Chief Development Officer, Pfizer Rare Disease

E

Ed Mathers

Partner, NEA

F

Fran Schulz

Independent Board Member

D

Donald Tang

Managing Partner, Celadon Partners

View 26 more team members with Pro

Unlock Full Team Directory

Recent News